Follow the people · Insider
Martin Wilson
Martin Wilson files insider transactions with the SEC as a general counsel of Rocket Pharmaceuticals (RCKT). We hold 6 disclosed purchases and sales filed since 26 April 2017, 2 of them in the last 90 days.
- Files forRCKT
- Disclosed buys and sells6 in all, 2 in the last 90 days
- Last disclosure20 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 December 2021 — 18 August 2026General Counsel · Rocket Pharmaceuticals (RCKT)43 Form 4 lines · source: SEC Form 4
- Filed 25 April 2017 — 19 February 2019General Counsel · Teligent (TLGT)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
50 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 631 shares of Rocket PharmaceuticalsSEC Form 420 August 2026Common Stock · traded 18 August 2026 · filed 20 August 2026
- ▼ sold on the open market 3,493 shares of Rocket PharmaceuticalsSEC Form 417 August 2026Common Stock · traded 13 August 2026 · filed 17 August 2026
- ▼ sold on the open market 662 shares of Rocket PharmaceuticalsSEC Form 421 May 2026Common Stock · traded 19 May 2026 · filed 21 May 2026
- ▼ sold on the open market 3,361 shares of Rocket PharmaceuticalsSEC Form 414 May 2026Common Stock · traded 13 May 2026 · filed 14 May 2026
- ▼ sold on the open market 1,376 shares of Rocket PharmaceuticalsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 1,376 shares of Rocket PharmaceuticalsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 12,253 shares of Rocket PharmaceuticalsSEC Form 418 February 2026Common Stock · traded 13 February 2026 · filed 18 February 2026
- ▼ sold on the open market 12,253 shares of Rocket PharmaceuticalsSEC Form 418 February 2026Common Stock · traded 13 February 2026 · filed 18 February 2026
- was granted 311,813 shares of Rocket PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- was granted 468,187 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Option (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- was granted 468,187 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Option (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- was granted 311,813 shares of Rocket PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- ▼ sold on the open market 1,646 shares of Rocket PharmaceuticalsSEC Form 420 November 2025Common Stock · traded 18 November 2025 · filed 20 November 2025
- was granted 100,000 shares of Rocket PharmaceuticalsSEC Form 410 November 2025Common Stock · traded 3 November 2025 · filed 10 November 2025
- was granted 150,000 shares of Rocket PharmaceuticalsSEC Form 49 September 2025Common Stock · traded 8 September 2025 · filed 9 September 2025
- ▼ sold on the open market 1,004 shares of Rocket PharmaceuticalsSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- ▼ sold on the open market 588 shares of Rocket PharmaceuticalsSEC Form 420 August 2025Common Stock · traded 19 August 2025 · filed 20 August 2025
- ▼ sold on the open market 12,109 shares of Rocket PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 14 August 2025 · filed 18 August 2025
- ▼ sold on the open market 587 shares of Rocket PharmaceuticalsSEC Form 422 May 2025Common Stock · traded 20 May 2025 · filed 22 May 2025
- ▼ sold on the open market 946 shares of Rocket PharmaceuticalsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- ▼ sold on the open market 3,222 shares of Rocket PharmaceuticalsSEC Form 425 February 2025Common Stock · traded 21 February 2025 · filed 25 February 2025
- was granted 134,642 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 413 February 2025Stock Option (Right to Buy) · traded 11 February 2025 · filed 13 February 2025
- was granted 90,358 shares of Rocket PharmaceuticalsSEC Form 413 February 2025Common Stock · traded 11 February 2025 · filed 13 February 2025
- ▼ sold on the open market 1,175 shares of Rocket PharmaceuticalsSEC Form 425 November 2024Common Stock · traded 21 November 2024 · filed 25 November 2024
- ▼ sold on the open market 1,027 shares of Rocket PharmaceuticalsSEC Form 420 August 2024Common Stock · traded 16 August 2024 · filed 20 August 2024
- exercised options over 2,420 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 420 May 2024Restricted Stock Units · traded 14 May 2024 · filed 20 May 2024
- acquired or disposed of, other 28,763 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 420 May 2024Restricted Stock Units · traded 12 August 2022 · filed 20 May 2024
- acquired or disposed of, other 16,947 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 420 May 2024Restricted Stock Units · traded 14 February 2023 · filed 20 May 2024
- exercised options over 2,420 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 14 May 2024 · filed 20 May 2024
- acquired or disposed of, other 28,763 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 12 August 2022 · filed 20 May 2024
- acquired or disposed of, other 16,947 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 14 February 2023 · filed 20 May 2024
- ▼ sold on the open market 1,048 shares of Rocket PharmaceuticalsSEC Form 420 May 2024Common Stock · traded 16 May 2024 · filed 20 May 2024
- ▼ sold on the open market 4,100 shares of Rocket PharmaceuticalsSEC Form 44 March 2024Common Stock · traded 29 February 2024 · filed 4 March 2024
- was granted 49,091 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 421 February 2024Stock Option (Right to Buy) · traded 16 February 2024 · filed 21 February 2024
- ▼ sold on the open market 3,576 shares of Rocket PharmaceuticalsSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- was granted 16,644 shares of Rocket PharmaceuticalsSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- exercised options over 9,712 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2024Restricted Stock Units · traded 14 February 2024 · filed 16 February 2024
- exercised options over 9,712 shares of Rocket PharmaceuticalsSEC Form 416 February 2024Common Stock · traded 14 February 2024 · filed 16 February 2024
- was granted 87,147 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2023Stock Option (Right to Buy) · traded 14 February 2023 · filed 16 February 2023
- was granted 29,079 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 February 2023Restricted Stock Units · traded 14 February 2023 · filed 16 February 2023
- was granted 20,318 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 August 2022Stock Option (Right to Buy) · traded 12 August 2022 · filed 16 August 2022
- was granted 28,763 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 416 August 2022Restricted Stock Units · traded 12 August 2022 · filed 16 August 2022
- was granted 100,000 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 48 December 2021Stock Option (Right to Buy) · traded 6 December 2021 · filed 8 December 2021
- was granted 193,712 shares of Teligent (a derivative holding)SEC Form 421 February 2019Stock Option · traded 19 February 2019 · filed 21 February 2019
- exercised options over 5,000 shares of TeligentSEC Form 422 October 2018Common Stock · traded 25 April 2018 · filed 22 October 2018
- exercised options over 5,000 shares of Teligent (a derivative holding)SEC Form 422 October 2018Restricted Stock Units · traded 25 April 2018 · filed 22 October 2018
- was granted 22,105 shares of Teligent (a derivative holding)SEC Form 42 April 2018Stock Option · traded 22 March 2018 · filed 2 April 2018
- was granted 11,052 shares of Teligent (a derivative holding)SEC Form 42 April 2018Restricted Stock Unit · traded 22 March 2018 · filed 2 April 2018
- was granted 40,000 shares of Teligent (a derivative holding)SEC Form 426 April 2017Stock Option · traded 25 April 2017 · filed 26 April 2017
- was granted 15,000 shares of Teligent (a derivative holding)SEC Form 426 April 2017Restricted Stock Unit · traded 25 April 2017 · filed 26 April 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.